At-home test kits, new vaccine developments, and more COVID-19 updates

A roundup of the top stories you may have missed this week.

The coronavirus crisis is unique. Addressing it will require new ideas, new perspectives, and new voices. That’s our mission at Freethink.

In our weekly “Coronavirus News Roundup,” we’re highlighting the most important stories from the frontlines of the fight against COVID-19. Stories that inform, challenge, and inspire.

Here are our must reads for this week.

1. A Chinese Coronavirus Vaccine Advances to Phase II Trials

CanSino Bio’s in-development coronavirus vaccine was the second in the world to reach human trials — and it’s now the first to advance to the second stage of human testing.

2. The FDA Authorizes the First At-Home Coronavirus Test Kit

For the first time, people have the option of collecting their own coronavirus samples at home, a development that could both increase access to testing and help prevent the spread of the coronavirus.

3. We May Need Fewer Ventilators for COVID-19 Patients Than We Expected

New research suggests that healthcare workers may be overusing ventilators for COVID-19 patients — meaning there might be more of the machines to go around than previously thought.

4. Microsoft’s “Plasma Bot” Helps You Donate Plasma for COVID-19

Microsoft created an online bot to help guide coronavirus survivors through the process of donating their antibody-rich plasma — a move that could help advance COVID-19 trials and research.

5. Ghana Is Using Drones to Speed Up Its Coronavirus Testing

The African nation of Ghana is using autonomous drones to transport coronavirus test samples from rural areas to two city labs — and the devices might be flying over the U.S. in the near future.

Related
Viruses may one day treat inflammatory bowel disease
Researchers have created a cocktail of viruses that may be able to treat inflammatory bowel diseases like Crohn’s.
Nanoparticle sensor can distinguish between viral and bacterial pneumonia
MIT researchers have designed a sensor that can distinguish between viral and bacterial pneumonia infections.
Yale study finds low levels of a hormone may predict long COVID
Yale and Icahn School of Medicine researchers may have found biomarkers for identifying long COVID.
Only human Lyme vaccine in development enters phase 3 trial
Pfizer and French biotech Valneva have announced a phase 3 clinical trial testing the human Lyme vaccine.
vaccine waste
Half of all vaccines are wasted. A gel could save them.
A new hydrogel that wraps around heat-sensitive molecules could help prevent vaccine waste by keeping them viable at higher temperatures.
Up Next
Subscribe to Freethink for more great stories